Compassionate Use – Psychedelic Therapy for Those Who Can’t Wait
“Obviously, bureaucracy is not a human being. People have compassion. Bureaucracies don’t always have compassion.' -- Spencer Hawkswell
Health - Page 9
Equity and Accessibility of MDMA-Assisted Therapy
Psychedelic medicine continues to move forward, but minority communities are being left behind.
Exploratory Study Indicates Psilocybin Provides Relief for Migraines
Interestingly, changes in migraine frequency were not correlated with the intensity of the acute psychotropic effects.
Methoxetamine: Cousin of Ketamine
The characterization of methoxetamine, a ketamine analog, and how its action on the serotonin system sets it apart.
DMT Research Affords New Hope for Stroke Victims
A recent study shows DMT reduces the cellular stress caused by a stroke and speeds up recovery time in rats. These findings highlight the expanding therapeutic potential of DMT regarding neurological disorders.
It Takes Guts: Psychedelic Treatment Approaches to Autoimmune Disorders
There is much research into psychedelic treatment of mental disorders, but psychedelics might be effective in treating autoimmune disorders as well.
The Top 10 Psychedelic Research Papers of 2020
Psychedelic-assisted psychotherapy leads the way in 2020’s top psychedelic papers.
How to Change Your Ability to Change
The monoamine hypothesis of depression leaves many patients without effective help. It’s time for a paradigm shift, and psychedelics may be leading the way.
Pilot Study of Psilocybin-Assisted Group Therapy in Older AIDS Survivors
Feasibility, safety, and potential efficacy of psilocybin-assisted group therapy was demonstrated in treating demoralization in this marginalized population.
ACT and PcbAP for Depression – A Natural Synergy Part 2: The Technical Integration
Harnessing the theoretical and technical synergy between Acceptance and Commitment Therapy (ACT) and Psychedelic Assisted Psychotherapy (PcbAP)